Edition:
United States

GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

35.06USD
17 Nov 2017
Change (% chg)

$-0.13 (-0.37%)
Prev Close
$35.19
Open
$35.06
Day's High
$35.15
Day's Low
$34.88
Volume
2,585,274
Avg. Vol
3,977,647
52-wk High
$44.53
52-wk Low
$34.72

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 10,040.70 10,407.90 9,700.13 9,528.40
Quarter Ending Mar-18 1 10,602.10 10,602.10 10,602.10 --
Year Ending Dec-17 5 39,904.00 40,602.30 39,366.30 36,544.20
Year Ending Dec-18 5 40,520.20 42,421.80 39,703.90 37,665.70
Earnings (per share)
Quarter Ending Dec-17 1 0.68 0.68 0.68 --
Year Ending Dec-17 4 2.91 2.93 2.87 2.75
Year Ending Dec-18 5 2.81 2.90 2.72 2.71
LT Growth Rate (%) 1 9.00 9.00 9.00 11.75
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 27.93 31.35 34.53
P/E High - Last 5 Yrs. 83.92 40.48 45.15
P/E Low - Last 5 Yrs. 7.83 23.53 24.17
Beta 0.98 0.91 0.89
Price to Sales (TTM) 2.13 3.84 5.22
Price to Book (MRQ) 50.44 4.70 5.51
Price to Tangible Book (MRQ) -- 5.47 6.98
Price to Cash Flow (TTM) 12.31 22.63 23.49
% Owned Institutions 10.31 0.74 1.29

Dividends

  Company industry sector
Dividend Yield 5.89 1.57 1.50
Dividend Yield - 5 Year Avg 5.47 2.15 2.03
Dividend 5 Year Growth Rate 2.71 4.36 5.30
Payout Ratio(TTM) 167.24 46.55 45.45

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 3.99 6.34 6.95
Sales (TTM) vs TTM 1 Yr. Ago 13.33 4.71 5.19
Sales - 5 Yr. Growth Rate 0.36 10.10 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.84 4.35 4.91
EPS (TTM) vs TTM 1 Yr. Ago 692.34 -- --
EPS - 5 Yr. Growth Rate -28.87 10.04 11.02
Capital Spending - 5 Yr. Growth Rate 12.11 15.12 15.09

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.44 2.49 2.53
Current Ratio (MRQ) 0.64 3.49 3.53
LT Debt to Equity (MRQ) 1,104.64 9.88 12.25
Total Debt to Equity (MRQ) 1,470.94 15.89 18.21
Interest Coverage (TTM) 8.95 48.83 43.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 69.30 55.06 54.77
Gross Margin - 5 Yr. Avg. 69.11 52.09 52.26
EBITD Margin (TTM) 36.05 -- --
EBITD - 5 Yr. Avg 32.70 18.36 15.69
Operating Margin (TTM) 13.93 14.65 8.05
Operating Margin - 5 Yr. Avg. 25.02 14.45 11.32
Pre-Tax Margin (TTM) 11.64 15.07 8.85
Pre-Tax Margin - 5 Yr. Avg. 22.45 14.78 11.74
Net Profit Margin (TTM) 9.45 11.25 5.09
Net Profit Margin - 5 Yr. Avg. 17.67 11.10 8.01
Effective Tax Rate (TTM) 18.74 24.32 24.22
Effective Tax Rate - 5 Yr. Avg. 21.30 23.46 24.08

Efficiency

  Company industry sector
Revenue/Employee (TTM) 398,780 956,921,905 862,067,509
Net Income/Employee (TTM) 37,704 111,638,953 100,498,038
Receivable Turnover (TTM) 4.43 5.82 6.11
Inventory Turnover (TTM) 1.68 2.72 3.51
Asset Turnover (TTM) 0.51 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.85 11.89 11.35
Return on Assets - 5 Yr. Avg. 9.91 12.97 12.39
Return on Investment (TTM) 8.82 15.11 14.52
Return on Investment - 5 Yr. Avg. 15.25 16.96 16.22
Return on Equity (TTM) 326.12 16.52 16.01
Return on Equity - 5 Yr. Avg. 82.33 17.91 17.36
  1 Year 3 Year 5 Year
Sales % 16.58 1.71 0.36
EPS (TTM) % -89.20 -44.79 -28.87
Dividend % 0.00 0.85 2.71
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.15 -14.27 26 10
13 Week -9.52 -14.90 42 13
26 Week -19.59 -25.73 47 27
52 Week -8.82 -22.67 67 19
YTD -8.96 -20.96 65 22
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.31%
# of Holders: 850
Total Shares Held: 253,470,681
3 Mo. Net Change: 14,002,575
# New Positions: 43
# Closed Positions: 78
# Increased Positions: 352
# Reduced Positions: 330
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.